Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Seattle Children's Hospital
mi
from
Seattle, WA
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Research Institute of Manitoba
mi
from
Winnipeg,
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Research Institute of Manitoba
mi
from
Winnipeg,
Click here to add this to my saved trials
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Status: Enrolling
Updated:  12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Status: Enrolling
Updated: 12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Status: Enrolling
Updated:  12/31/1969
Geisinger Wyoming Valley Medical Center
mi
from
Wilkes-Barre, PA
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Status: Enrolling
Updated: 12/31/1969
Geisinger Wyoming Valley Medical Center
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Iron Deficiency and FGF23 Regulation in CKD and HF
Iron Deficiency and Fibroblast Growth Factor 23 Regulation in Chronic Kidney Disease and Heart Failure
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
Iron Deficiency and FGF23 Regulation in CKD and HF
Iron Deficiency and Fibroblast Growth Factor 23 Regulation in Chronic Kidney Disease and Heart Failure
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
The Use of Nesiritide in Thoracic Aneurysm Repair to Prevent Acute Renal Failure
Prophylactic Use of Nesiritide (Brain Natriuretic Peptide, BNP) for the Prevention of Acute Renal Failure in Thoracic Aortic Aneurysm Surgery Patients
Status: Enrolling
Updated:  6/23/2005
Shands Hospital at the University of Florida
mi
from
Gainesville, FL
The Use of Nesiritide in Thoracic Aneurysm Repair to Prevent Acute Renal Failure
Prophylactic Use of Nesiritide (Brain Natriuretic Peptide, BNP) for the Prevention of Acute Renal Failure in Thoracic Aortic Aneurysm Surgery Patients
Status: Enrolling
Updated: 6/23/2005
Shands Hospital at the University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Glomerular Filtration Rate (GFR) Reporting on Nephrology Referral Patterns by Internists
The Effect of MDRD GFR Reporting on Nephrology Referral Patterns by Internists
Status: Enrolling
Updated:  11/4/2005
Naval Medical Center - San Diego
mi
from
San Diego, CA
Glomerular Filtration Rate (GFR) Reporting on Nephrology Referral Patterns by Internists
The Effect of MDRD GFR Reporting on Nephrology Referral Patterns by Internists
Status: Enrolling
Updated: 11/4/2005
Naval Medical Center - San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
The Effects of Cool Dialysate on the Sleep/Wake Cycle in Patients on Chronic Hemodialysis - "The Sleep Cool Study"
The Effects of Hemodialysis on the Sleep/Wake Cycle
Status: Enrolling
Updated:  11/21/2005
Emory University affiliated hemodialysis units
mi
from
Atlanta, GA
The Effects of Cool Dialysate on the Sleep/Wake Cycle in Patients on Chronic Hemodialysis - "The Sleep Cool Study"
The Effects of Hemodialysis on the Sleep/Wake Cycle
Status: Enrolling
Updated: 11/21/2005
Emory University affiliated hemodialysis units
mi
from
Atlanta, GA
Click here to add this to my saved trials
Nutrition Counseling to Lower Serum Phosphorus Levels
Comparison of Different Counseling Methods on Serum Phosphorus Levels in Renal Patients at Hines VA Hospital
Status: Enrolling
Updated:  2/23/2006
Edward Hines,Jr., VA Hospital
mi
from
Hines, IL
Nutrition Counseling to Lower Serum Phosphorus Levels
Comparison of Different Counseling Methods on Serum Phosphorus Levels in Renal Patients at Hines VA Hospital
Status: Enrolling
Updated: 2/23/2006
Edward Hines,Jr., VA Hospital
mi
from
Hines, IL
Click here to add this to my saved trials
Nutrition Counseling to Lower Serum Phosphorus Levels
Comparison of Different Counseling Methods on Serum Phosphorus Levels in Renal Patients at Hines VA Hospital
Status: Enrolling
Updated:  2/23/2006
Hines VA Hospital
mi
from
Hines, IL
Nutrition Counseling to Lower Serum Phosphorus Levels
Comparison of Different Counseling Methods on Serum Phosphorus Levels in Renal Patients at Hines VA Hospital
Status: Enrolling
Updated: 2/23/2006
Hines VA Hospital
mi
from
Hines, IL
Click here to add this to my saved trials
Web Based Renal Transplant Patient Medication Education
Web Based Renal Transplant Patient Medication Education
Status: Enrolling
Updated:  5/16/2006
Yale-New Haven Hospital
mi
from
New Haven, CT
Web Based Renal Transplant Patient Medication Education
Web Based Renal Transplant Patient Medication Education
Status: Enrolling
Updated: 5/16/2006
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Niaspan in Diabetic Nephropathy
Randomized, Double-Blind, Placebo-Controlled Trial of Niaspan® in Patients With Overt Diabetic Nephropathy and Moderate Renal Impairment
Status: Enrolling
Updated:  11/8/2006
Jackson Memorial Hospital
mi
from
Miami, FL
Niaspan in Diabetic Nephropathy
Randomized, Double-Blind, Placebo-Controlled Trial of Niaspan® in Patients With Overt Diabetic Nephropathy and Moderate Renal Impairment
Status: Enrolling
Updated: 11/8/2006
Jackson Memorial Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Niaspan in Diabetic Nephropathy
Randomized, Double-Blind, Placebo-Controlled Trial of Niaspan® in Patients With Overt Diabetic Nephropathy and Moderate Renal Impairment
Status: Enrolling
Updated:  11/8/2006
Diabetes Research Institute
mi
from
Miami, FL
Niaspan in Diabetic Nephropathy
Randomized, Double-Blind, Placebo-Controlled Trial of Niaspan® in Patients With Overt Diabetic Nephropathy and Moderate Renal Impairment
Status: Enrolling
Updated: 11/8/2006
Diabetes Research Institute
mi
from
Miami, FL
Click here to add this to my saved trials
ADMA Levels in End-Stage Renal Disease
Determination of Asymmetrical Dimethylarginine (ADMA) Accumulation in End Stage Renal Disease
Status: Enrolling
Updated:  12/1/2006
University of Michigan Health System
mi
from
Ann Arbor, MI
ADMA Levels in End-Stage Renal Disease
Determination of Asymmetrical Dimethylarginine (ADMA) Accumulation in End Stage Renal Disease
Status: Enrolling
Updated: 12/1/2006
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
More Frequent Dialysis (>3 Treatments Per Week)
Study of Clinical Outcomes of More Frequent Hemodialysis
Status: Enrolling
Updated:  12/17/2007
Satellite Healthcare, Inc.
mi
from
Mountain View, CA
More Frequent Dialysis (>3 Treatments Per Week)
Study of Clinical Outcomes of More Frequent Hemodialysis
Status: Enrolling
Updated: 12/17/2007
Satellite Healthcare, Inc.
mi
from
Mountain View, CA
Click here to add this to my saved trials
More Frequent Dialysis (>3 Treatments Per Week)
Study of Clinical Outcomes of More Frequent Hemodialysis
Status: Enrolling
Updated:  12/17/2007
WellBound, Inc.
mi
from
Mountain View, CA
More Frequent Dialysis (>3 Treatments Per Week)
Study of Clinical Outcomes of More Frequent Hemodialysis
Status: Enrolling
Updated: 12/17/2007
WellBound, Inc.
mi
from
Mountain View, CA
Click here to add this to my saved trials
Effect of Parenteral Iron Therapy on Inflammatory Response and Oxidative Stress Chronic Hemodialysis
The Effect of Parenteral Iron Therapy on the Systemic Inflammatory Response and Oxidative Stress in Chronic Hemodialysis Patients
Status: Enrolling
Updated:  12/31/2007
Dialysis Clinics Inc
mi
from
Sacramento, CA
Effect of Parenteral Iron Therapy on Inflammatory Response and Oxidative Stress Chronic Hemodialysis
The Effect of Parenteral Iron Therapy on the Systemic Inflammatory Response and Oxidative Stress in Chronic Hemodialysis Patients
Status: Enrolling
Updated: 12/31/2007
Dialysis Clinics Inc
mi
from
Sacramento, CA
Click here to add this to my saved trials
Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
Status: Enrolling
Updated:  1/8/2008
Satellite Healthcare, Inc.
mi
from
Mountain View, CA
Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
Status: Enrolling
Updated: 1/8/2008
Satellite Healthcare, Inc.
mi
from
Mountain View, CA
Click here to add this to my saved trials
Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
Status: Enrolling
Updated:  1/8/2008
WellBound, Inc.
mi
from
Mountain View, CA
Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
Status: Enrolling
Updated: 1/8/2008
WellBound, Inc.
mi
from
Mountain View, CA
Click here to add this to my saved trials
Comparison of Dialysis Therapies on Cognitive Function
Comparison of Dialysis Therapies on Cognitive Function
Status: Enrolling
Updated:  1/8/2008
Satellite Healthcare, Inc.
mi
from
Mountain View, CA
Comparison of Dialysis Therapies on Cognitive Function
Comparison of Dialysis Therapies on Cognitive Function
Status: Enrolling
Updated: 1/8/2008
Satellite Healthcare, Inc.
mi
from
Mountain View, CA
Click here to add this to my saved trials
Comparison of Dialysis Therapies on Cognitive Function
Comparison of Dialysis Therapies on Cognitive Function
Status: Enrolling
Updated:  1/8/2008
WellBound, Inc.
mi
from
Mountain View, CA
Comparison of Dialysis Therapies on Cognitive Function
Comparison of Dialysis Therapies on Cognitive Function
Status: Enrolling
Updated: 1/8/2008
WellBound, Inc.
mi
from
Mountain View, CA
Click here to add this to my saved trials
Impact of CAMP in an Ambulatory Renal Clinic
Impact of a Pharmacist's Collaborative Management, Adherence,and Medication Education Program (CAMP) in an Ambulatory Renal Clinic
Status: Enrolling
Updated:  2/14/2008
VA Medical Center, San Francisco
mi
from
San Francisco, CA
Impact of CAMP in an Ambulatory Renal Clinic
Impact of a Pharmacist's Collaborative Management, Adherence,and Medication Education Program (CAMP) in an Ambulatory Renal Clinic
Status: Enrolling
Updated: 2/14/2008
VA Medical Center, San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Cognitive and Functional Status and Dialysis Outcomes in Older Hemodialysis Patients
Cognitive and Functional Status and Dialysis Outcomes in Older Hemodialysis Patients
Status: Enrolling
Updated:  8/21/2008
University of Chicago Chronic Hemodialysis Centers
mi
from
Chicago, IL
Cognitive and Functional Status and Dialysis Outcomes in Older Hemodialysis Patients
Cognitive and Functional Status and Dialysis Outcomes in Older Hemodialysis Patients
Status: Enrolling
Updated: 8/21/2008
University of Chicago Chronic Hemodialysis Centers
mi
from
Chicago, IL
Click here to add this to my saved trials
Renal Blood Flow Measurement With Positron Emission Tomography (PET)
Renal Blood Flow Measurement With PET
Status: Enrolling
Updated:  9/2/2008
University of Wisconsin-Madison
mi
from
Madison, WI
Renal Blood Flow Measurement With Positron Emission Tomography (PET)
Renal Blood Flow Measurement With PET
Status: Enrolling
Updated: 9/2/2008
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients
An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients
Status: Enrolling
Updated:  2/2/2009
Simi Valley Dialysis Center
mi
from
Simi Valley, CA
An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients
An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients
Status: Enrolling
Updated: 2/2/2009
Simi Valley Dialysis Center
mi
from
Simi Valley, CA
Click here to add this to my saved trials
The Differential Effects of 3 Different Immunosuppressive
The Differential Effects of 3 Different Immunosuppressive Agents, Tacrolimus Mycophenolate Mofetil and Sirolimus on the Generation of Tregs and DCregs in in Vitro MLR and T Cell Activation Assays
Status: Enrolling
Updated:  2/3/2009
Northwestern Memorial Hospital
mi
from
Chicago, IL
The Differential Effects of 3 Different Immunosuppressive
The Differential Effects of 3 Different Immunosuppressive Agents, Tacrolimus Mycophenolate Mofetil and Sirolimus on the Generation of Tregs and DCregs in in Vitro MLR and T Cell Activation Assays
Status: Enrolling
Updated: 2/3/2009
Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Assessing Novel Methods of Improving Patient Education of Nutrition
Assessing Novel Methods of Improving Patient Education of Nutrition: eHealth, Health Literacy and Chronic Kidney Disease
Status: Enrolling
Updated:  2/13/2009
UW Health Kidney Clinic and Wisconsin Dialysis
mi
from
Madison, WI
Assessing Novel Methods of Improving Patient Education of Nutrition
Assessing Novel Methods of Improving Patient Education of Nutrition: eHealth, Health Literacy and Chronic Kidney Disease
Status: Enrolling
Updated: 2/13/2009
UW Health Kidney Clinic and Wisconsin Dialysis
mi
from
Madison, WI
Click here to add this to my saved trials
Fiber Intake in an End Stage Renal Disease (ESRD) Population Followed Over 2 Years
Fiber Content of Hemodialysis Patients' Diet and it's Cardiovascular Implications.
Status: Enrolling
Updated:  4/1/2009
Staten Island University Hospital
mi
from
Staten Island, NY
Fiber Intake in an End Stage Renal Disease (ESRD) Population Followed Over 2 Years
Fiber Content of Hemodialysis Patients' Diet and it's Cardiovascular Implications.
Status: Enrolling
Updated: 4/1/2009
Staten Island University Hospital
mi
from
Staten Island, NY
Click here to add this to my saved trials
IV Insulin Protocol in Diabetes and Renal Transplantation
Intravenous Insulin Protocol in Diabetes and Renal Transplantation Study
Status: Enrolling
Updated:  4/21/2009
Medical University of South Carolina
mi
from
Charleston, SC
IV Insulin Protocol in Diabetes and Renal Transplantation
Intravenous Insulin Protocol in Diabetes and Renal Transplantation Study
Status: Enrolling
Updated: 4/21/2009
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)
Fibroblast Growth Factor-23 Reduction in Predialysis Chronic Kidney Disease
Status: Enrolling
Updated:  5/21/2009
University of Miami Hospital
mi
from
Miami, FL
Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)
Fibroblast Growth Factor-23 Reduction in Predialysis Chronic Kidney Disease
Status: Enrolling
Updated: 5/21/2009
University of Miami Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry
The Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry: Prospective, Randomized, Controlled Study
Status: Enrolling
Updated:  8/3/2009
University of Kentucky Medical Center
mi
from
Lexington, KY
Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry
The Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry: Prospective, Randomized, Controlled Study
Status: Enrolling
Updated: 8/3/2009
University of Kentucky Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry
The Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry: Prospective, Randomized, Controlled Study
Status: Enrolling
Updated:  8/3/2009
FMC Clinics
mi
from
Bornova,
Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry
The Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry: Prospective, Randomized, Controlled Study
Status: Enrolling
Updated: 8/3/2009
FMC Clinics
mi
from
Bornova,
Click here to add this to my saved trials
Analysis of Calcium Balance in Chronic Kidney Disease
Analysis of Calcium Balance in Chronic Kidney Disease
Status: Enrolling
Updated:  9/9/2009
Univ. of Colorado at Denver and Health Sciences Center
mi
from
Aurora, CO
Analysis of Calcium Balance in Chronic Kidney Disease
Analysis of Calcium Balance in Chronic Kidney Disease
Status: Enrolling
Updated: 9/9/2009
Univ. of Colorado at Denver and Health Sciences Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Effect of Intravenous Acetadote on Incidence of Contrast Induced Nephropathy
N-Acetylcysteine to Prevent Contrast-Induced Nephropathy in Acute Coronary Syndromes
Status: Enrolling
Updated:  9/17/2009
Ochsner Medical Center
mi
from
New Orleans, LA
Effect of Intravenous Acetadote on Incidence of Contrast Induced Nephropathy
N-Acetylcysteine to Prevent Contrast-Induced Nephropathy in Acute Coronary Syndromes
Status: Enrolling
Updated: 9/17/2009
Ochsner Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Impact of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients
Prospective Trial of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients With Chronic Allograft Nephropathy
Status: Enrolling
Updated:  10/20/2009
Temple University
mi
from
Philadelphia, PA
Impact of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients
Prospective Trial of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients With Chronic Allograft Nephropathy
Status: Enrolling
Updated: 10/20/2009
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Behavioral Intervention and Adherence in Dialysis
Behavioral Intervention and Adherence in Dialysis
Status: Enrolling
Updated:  2/9/2010
Tri-State Dialysis
mi
from
Dubuque, IA
Behavioral Intervention and Adherence in Dialysis
Behavioral Intervention and Adherence in Dialysis
Status: Enrolling
Updated: 2/9/2010
Tri-State Dialysis
mi
from
Dubuque, IA
Click here to add this to my saved trials
Behavioral Intervention and Adherence in Dialysis
Behavioral Intervention and Adherence in Dialysis
Status: Enrolling
Updated:  2/9/2010
University of Iowa renal dialysis program
mi
from
Iowa City, IA
Behavioral Intervention and Adherence in Dialysis
Behavioral Intervention and Adherence in Dialysis
Status: Enrolling
Updated: 2/9/2010
University of Iowa renal dialysis program
mi
from
Iowa City, IA
Click here to add this to my saved trials
National Cooperative Growth Study of Nutropin AQ, Nutropin, Protropin, and Nutropin Depot in Children With Growth Failure Due to Chronic Renal Insufficiency or End-Stage Renal Disease
National Cooperative Growth Study of Nutropin AQ, Nutropin, Protropin, and Nutropin Depot in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End-Stage Renal Disease (ESRD)
Status: Enrolling
Updated:  3/23/2010
UC Davis Medical Center
mi
from
Sacramento, CA
National Cooperative Growth Study of Nutropin AQ, Nutropin, Protropin, and Nutropin Depot in Children With Growth Failure Due to Chronic Renal Insufficiency or End-Stage Renal Disease
National Cooperative Growth Study of Nutropin AQ, Nutropin, Protropin, and Nutropin Depot in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End-Stage Renal Disease (ESRD)
Status: Enrolling
Updated: 3/23/2010
UC Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients
An Open Label, Multi-Center Study of the Effect of Paricalcitol on Markers of Inflammation in Patients With Stage 5 Chronic Kidney Disease on Hemodialysis.
Status: Enrolling
Updated:  4/7/2010
Southwest Nephrology
mi
from
Evergreen Park, IL
Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients
An Open Label, Multi-Center Study of the Effect of Paricalcitol on Markers of Inflammation in Patients With Stage 5 Chronic Kidney Disease on Hemodialysis.
Status: Enrolling
Updated: 4/7/2010
Southwest Nephrology
mi
from
Evergreen Park, IL
Click here to add this to my saved trials
Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients
An Open Label, Multi-Center Study of the Effect of Paricalcitol on Markers of Inflammation in Patients With Stage 5 Chronic Kidney Disease on Hemodialysis.
Status: Enrolling
Updated:  4/7/2010
Nephrology Center
mi
from
Kalamazoo, MI
Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients
An Open Label, Multi-Center Study of the Effect of Paricalcitol on Markers of Inflammation in Patients With Stage 5 Chronic Kidney Disease on Hemodialysis.
Status: Enrolling
Updated: 4/7/2010
Nephrology Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients
An Open Label, Multi-Center Study of the Effect of Paricalcitol on Markers of Inflammation in Patients With Stage 5 Chronic Kidney Disease on Hemodialysis.
Status: Enrolling
Updated:  4/7/2010
Nephrology Associates P.A.
mi
from
West Orange, NJ
Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients
An Open Label, Multi-Center Study of the Effect of Paricalcitol on Markers of Inflammation in Patients With Stage 5 Chronic Kidney Disease on Hemodialysis.
Status: Enrolling
Updated: 4/7/2010
Nephrology Associates P.A.
mi
from
West Orange, NJ
Click here to add this to my saved trials
Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients
An Open Label, Multi-Center Study of the Effect of Paricalcitol on Markers of Inflammation in Patients With Stage 5 Chronic Kidney Disease on Hemodialysis.
Status: Enrolling
Updated:  4/7/2010
Delaware Valley Nephrology
mi
from
Philadelphia, PA
Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients
An Open Label, Multi-Center Study of the Effect of Paricalcitol on Markers of Inflammation in Patients With Stage 5 Chronic Kidney Disease on Hemodialysis.
Status: Enrolling
Updated: 4/7/2010
Delaware Valley Nephrology
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients
An Open Label, Multi-Center Study of the Effect of Paricalcitol on Markers of Inflammation in Patients With Stage 5 Chronic Kidney Disease on Hemodialysis.
Status: Enrolling
Updated:  4/7/2010
Nephrology Associates, PC
mi
from
Nashville, TN
Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients
An Open Label, Multi-Center Study of the Effect of Paricalcitol on Markers of Inflammation in Patients With Stage 5 Chronic Kidney Disease on Hemodialysis.
Status: Enrolling
Updated: 4/7/2010
Nephrology Associates, PC
mi
from
Nashville, TN
Click here to add this to my saved trials
Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients
An Open Label, Multi-Center Study of the Effect of Paricalcitol on Markers of Inflammation in Patients With Stage 5 Chronic Kidney Disease on Hemodialysis.
Status: Enrolling
Updated:  4/7/2010
Tyler Nephrology Associates, PC
mi
from
Tyler, TX
Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients
An Open Label, Multi-Center Study of the Effect of Paricalcitol on Markers of Inflammation in Patients With Stage 5 Chronic Kidney Disease on Hemodialysis.
Status: Enrolling
Updated: 4/7/2010
Tyler Nephrology Associates, PC
mi
from
Tyler, TX
Click here to add this to my saved trials
Prevention of Acute Kidney Injury in Cardiac Surgery Patients
Prevention of Acute Kidney Injury in Cardiac Surgery Patients
Status: Enrolling
Updated:  5/26/2010
Community Medical Center
mi
from
Scranton, PA
Prevention of Acute Kidney Injury in Cardiac Surgery Patients
Prevention of Acute Kidney Injury in Cardiac Surgery Patients
Status: Enrolling
Updated: 5/26/2010
Community Medical Center
mi
from
Scranton, PA
Click here to add this to my saved trials
Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
Status: Enrolling
Updated:  6/24/2010
University of Michigan Dialysis Center
mi
from
Ann Arbor, MI
Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
Status: Enrolling
Updated: 6/24/2010
University of Michigan Dialysis Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
Status: Enrolling
Updated:  6/24/2010
University of Michigan Dialysis Center
mi
from
Livonia, MI
Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
Status: Enrolling
Updated: 6/24/2010
University of Michigan Dialysis Center
mi
from
Livonia, MI
Click here to add this to my saved trials
Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD): The Role of Biomarkers in Predicting a Response to Therapy
Rapamycin as Treatment for ADPKD: The Role of Biomarkers in Predicting a Response to Therapy
Status: Enrolling
Updated:  6/28/2010
Yale Center for Clinical Investigation
mi
from
New Haven, CT
Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD): The Role of Biomarkers in Predicting a Response to Therapy
Rapamycin as Treatment for ADPKD: The Role of Biomarkers in Predicting a Response to Therapy
Status: Enrolling
Updated: 6/28/2010
Yale Center for Clinical Investigation
mi
from
New Haven, CT
Click here to add this to my saved trials
Rifaximin Versus Lactulose in Renal Failure
A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Progressive Renal Failure
Status: Enrolling
Updated:  1/3/2011
Weill Cornell Medical Center
mi
from
New York, NY
Rifaximin Versus Lactulose in Renal Failure
A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Progressive Renal Failure
Status: Enrolling
Updated: 1/3/2011
Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials